Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 30 kwi 2024 · Abstract. Our previous study in children and young people (CYP) at 3- and 6-months post-infection showed that 12–16% of those infected with the Omicron (B.1.1.529) variant of SARS-CoV-2 met the...

  2. 23 cze 2022 · The objective of this systematic review and meta-analyses is to estimate the prevalence of long-COVID in children and adolescents and to present the full spectrum of symptoms present after...

  3. 4 sie 2022 · Using a large medical claims database, CDC assessed nine potential post-COVID signs and symptoms (symptoms) and 15 potential post-COVID conditions among 781,419 U.S. children and adolescents aged 0–17 years with laboratory-confirmed COVID-19 (patients with COVID-19) compared with 2,344,257 U.S. children and adolescents without recognized ...

  4. 28 gru 2023 · Among the 8 children with SARS-CoV-2 positive tests and PCC at 12-month follow-up, children reported respiratory (7 of 8 patients [88%]), systemic (3 of 8 patients [38%]), and neurologic (1 of 8 patients [13%]) symptoms.

  5. 20 kwi 2021 · The most common post-acute COVID-19 symptoms were mild post-viral cough (six [4%] of 151 children), fatigue (three [2%] children) or both post-viral cough and fatigue (one [1%] child). The duration of post-viral cough ranged from 3 weeks to 8 weeks and of post-viral fatigue ranged from 6 weeks to 8 weeks from the time of symptom onset.

  6. 21 lip 2023 · 26 participants reported long COVID symptoms at least 3 mo after the acute COVID-19 phase, including: fatigue, shortness of breath, exercise intolerance, weakness, walking intolerance, cough, sleep difficulty, muscle pain, joint pain, headache, and excess sputum.

  7. 12 mar 2022 · We found an asthma-like prevalence of 41.5% in the cohort of COVID-19 hospitalized children. Family history of asthma and previous history of asthma and allergic rhinitis are risk factors for asthma-like after COVID-19 hospitalization. COVID-19 presentations are more severe in the asthma-like group.